Here's what you need to know about the four CFTR (cystic fibrosis transmembrane conductance regulator) modulators.
Site Search
Showing 1 - 8 of 8 results
Press Release
|
Nov. 2, 2011
|
2 min read
Kalydeco Marks the Latest Success of the Cystic Fibrosis Foundation’s Venture Philanthropy Model
Press Release
|
Jan. 31, 2012
|
5 min read
CF Foundation Provided Scientific, Clinical and Significant Funding Support in Drug Development Process
Press Release
|
June 24, 2014
|
5 min read
Press Release
|
May 17, 2015
|
3 min read
This medicine represents the single greatest therapeutic advancement in the history of CF, offering a treatment for the underlying cause of the disease that could eventually benefit more than 90 percent of people with CF.
Press Release
|
Oct. 21, 2019
|
3 min read
Drug Targets the Underlying Cause of the Disease in People with the Most Common CF Mutation
Press Release
|
July 2, 2015
|
5 min read
Press Release
|
March 18, 2015
|
3 min read